share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  Jun 14 04:16
Summary by Futu AI
Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 15,000 Class A shares on 06/13/2024, with an aggregate market value of $139,798.24. The shares to be sold were acquired through restricted stock vesting and stock option exercise on 05/15/2023 and 06/13/2023, respectively. The securities were obtained directly from the issuer as part of compensation and cash payment. This planned transaction follows a series of sales over the past three months, where a total of 73,124 shares were sold for gross proceeds of $642,823.
Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 15,000 Class A shares on 06/13/2024, with an aggregate market value of $139,798.24. The shares to be sold were acquired through restricted stock vesting and stock option exercise on 05/15/2023 and 06/13/2023, respectively. The securities were obtained directly from the issuer as part of compensation and cash payment. This planned transaction follows a series of sales over the past three months, where a total of 73,124 shares were sold for gross proceeds of $642,823.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.